AJR F and L Medical Products: Radiation Protection & More
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Right arrow Help viewing high resolution images
Right arrow Return to article
Hotlight (NEW!)
Right arrow
What's Hotlight?

The following table or figure may be downloaded to PowerPoint for personal use in teaching and presentations. This feature is available to all subscribers to the journal.

You MUST read and follow the guidelines at Request to Reproduce AJR Content if you are distributing or using AJR content beyond academic use (limited distribution, non-revenue producing, or educational purposes).

(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)

Click on image to view larger version.


Figure 10


Fig. 5B 60-year-old man 2 years after radical prostatectomy for Gleason 6 prostate cancer. Pathology showed tumor focally at inked surface of left bladder base. Lymph nodes were negative for metastases. Postoperative prostate-specific antigen (PSA) was 0.1 until 1 year later, when it rose to 0.38. His most recent PSA was 0.55. To help minimize radiation dose to bladder and rectum, 111In capromab pendetide (222 MBq [6 mCi] IV) scintigraphy was requested for intensity-modulated radiation therapy planning. Multiplanar SPECT/CT clearly shows site of recurrence (thick arrow) from rectum (thin arrow).





Right arrow Return to article
Hotlight (NEW!)
Right arrow
What's Hotlight?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS